Overview

Dashboard News

bitcoin's potential to surpass gold in the evolving financial landscape

Bitcoin's capped supply of 21 million coins introduces a revolutionary form of digital scarcity, positioning it as a potential rival to gold as a store of value. Institutional adoption, including Bitcoin ETFs, is accelerating its integration into mainstream finance, despite skepticism from traditional investors. As adoption rates rise, Bitcoin's transformative power may redefine global financial systems, akin to the internet's evolution in the late 1990s.
Crypto News Flash
BlackRock, Inc. Larry Fink Jim Grant
Finance & Economy, Transcript
14:00 07.01.2025

Ripple enhances RLUSD stablecoin utility with Chainlink price feed integration

Ripple has integrated Chainlink's price feed to enhance the utility of its RLUSD stablecoin in decentralized finance (DeFi) applications. Launched last December and backed by the New York Department of Financial Services, RLUSD has a market cap of approximately $72 million and is available on various exchanges. This collaboration aims to provide reliable on-chain pricing data, essential for maintaining stability and trust in decentralized markets as RLUSD expands its reach across DeFi ecosystems.
Crypto Briefing
United States Dollar Ripple USD USD USA Johann Eid Jack Mcdonald
Crypto, Press Release
14:00 07.01.2025

Ripple partners with Chainlink to enhance RLUSD stablecoin in DeFi markets

Ripple has partnered with Chainlink to enhance the adoption of its RLUSD stablecoin in DeFi markets by providing reliable price feeds on Ethereum and the XRP Ledger. This collaboration aims to ensure accurate, tamper-proof data for RLUSD, which is pegged to the US dollar, facilitating secure transactions and supporting smart contracts. The integration is expected to accelerate RLUSD's utility in decentralized finance, bridging traditional finance with blockchain technology.
Cointelegraph
United States Dollar Coinbase Global, Inc. Ripples USD Chainlink USD ARE USA Colin Cunningham Show more
Crypto, News Article
14:00 07.01.2025

CRISPR Therapeutics nominates Briggs Morrison for Board of Directors position

CRISPR Therapeutics has proposed the election of Briggs Morrison, M.D., to its Board of Directors at the upcoming annual general meeting. With over 30 years in the pharmaceutical industry, Morrison's expertise in clinical development is expected to enhance the company's innovative gene-based medicine initiatives. CRISPR Therapeutics, which celebrated the approval of the first CRISPR-based therapy in 2023, continues to advance its diverse portfolio targeting serious diseases.
Yahoo Finance
United States Dollar Vertex Pharmaceuticals Inc Bayer AG CHE Briggs Morrison Samarth Kulkarni
Healthcare, Press Release
14:00 07.01.2025

trump's vision for america as the global crypto capital

The incoming Trump administration is poised to implement crypto-friendly regulations, potentially igniting a speculative frenzy in the market. Advocates believe this will solidify the U.S. as the leading force in global capital markets, with Trump envisioning America as the "crypto capital of the planet."
The Atlantic
USA Dennis Kelleher Donald Trump
Finance & Economy, Market Report
14:00 07.01.2025

jetbolt revolutionizes crypto with zero gas technology and user-friendly staking

JetBolt (JBOLT) is rapidly gaining traction in the crypto market, with over 250 million tokens sold in its presale. Its innovative zero-gas technology, powered by the Skale Network, enables fast, gas-free transactions, attracting developers to create new Web3 DApps.The platform's user-friendly Web3 wallet simplifies staking, allowing users to earn rewards through active engagement. With exclusive presale perks and a growing interest in next-gen tokens, JetBolt is positioning itself as a significant player in the crypto landscape.
Analytics Insight
Elon Musk
Technology & Innovation, Press Release
14:00 07.01.2025

crispr therapeutics proposes briggs morrison for board of directors appointment

[SEC](https://www.sec.gov) or [Bloomberg]
GlobeNewswire News Room
Vertex Pharmaceuticals Inc Bayer AG USA Briggs Morrison Samarth Kulkarni
Healthcare, Press Release
14:00 07.01.2025

crispr therapeutics proposes briggs morrison for board of directors election

CRISPR Therapeutics has proposed the election of Briggs Morrison, M.D., to its Board of Directors at the upcoming annual general meeting. With over 30 years in the pharmaceutical industry, including leadership roles at AstraZeneca and Pfizer, Morrison's expertise in clinical development is expected to enhance the company's innovative pipeline. He has overseen the development of notable drugs such as Tagrisso®, Imfinzi®, and Lynparza®.
@StockTitan_net
United States Dollar Vertex Pharmaceuticals Inc AstraZeneca PLC Bayer AG Pfizer Inc. Syndax Pharmaceuticals, Inc. Merck & Co., Inc. CHE Briggs Morrison Samarth Kulkarni Show more
Healthcare, Press Release
14:00 07.01.2025

ripple partners with chainlink to enhance rlusd stablecoin functionality

Ripple is integrating Chainlink's standard to enhance the utility of its new RLUSD stablecoin, which aims to challenge Tether and Circle's dominance in the market. This partnership will provide live price data and ongoing support, crucial for maintaining stability and trust as RLUSD expands across DeFi ecosystems. Following regulatory approval, RLUSD has already made strides in the Asian market with a listing on Singapore’s Independent Reserves exchange.
BeInCrypto
Singapore Dollar United States Dollar Coinbase Global, Inc. Ripples USD Chainlink USD USA Jack Mcdonald Show more
Finance & Economy, Press Release
14:00 07.01.2025

novartis gene therapy shows promise for treating spinal muscular atrophy in children

Novartis has reported that its intrathecal formulation of onasemnogene abeparvovec (OAV101 IT) met the primary endpoint in the phase 3 STEER study, potentially expanding treatment options for pediatric patients aged 2–17 with type II spinal muscular atrophy (SMA). The new formulation could benefit those with delayed diagnoses, especially in regions lacking newborn screening. If approved by regulatory agencies in 2025, OAV101 IT may significantly improve patient outcomes with its one-time infusion convenience.
PharmaTimes
United States Dollar Novartis AG USA Christie Wong
Healthcare, Market Report
13:52 07.01.2025
Trending
Subcategory:
Corporate News Stock Market Updates Industry Trends Banking Regulations Retail and Consumer Goods Startups & Entrepreneurship Global Financial Events Industry Mergers & Acquisitions Finance Mergers & Acquisitions European Securities and Markets Authority Government Policies CEO Changes Financial Scams and Security Private Equity Deals Government Economic Policies Domestic Politics Central Bank Actions Global Trade Developments Workplace Trends Market Analysis and Predictions
Countries:
USA DEU GBR CHN IND CHE ESP FRA ARE EGY CAN AUS HKG JPN NLD SAU KOR MEX ISR BRA
Companies:
DEUTSCHE BANK AG Barclays plc Natwest UBS AG Berkshire Hathaway Inc. MERCK KGaA Lloyds Banking Group plc Hsbc Holdings B.V. HSBC Holdings plc Rheinmetall AG Banco Santander SA Standard Chartered Delivery Hero SE Huawei Technologies CO. Ltd. Wells Fargo & Company ING Groep N.V. Unicredit adidas AG Google Inc. Dell Technologies Inc.
Currencies:
United States Dollar Euro British Pound Sterling Indian Rupee Swiss Franc Hong Kong Dollar Japanese Yen South Korean Won Chinese Yuan Canadian Dollar Saudi Riyal Australian Dollar Russian Ruble South African Rand Nicaraguan Córdoba United Arab Emirates Dirham Indonesian Rupiah Qatari Riyal Pakistani Rupee Egyptian Pound
People:
Elon Musk Donald Trump Meg Hillier Warren Buffett Joe Biden Thomas Müller Cristian Nedelcu Sven Weier Jason Napier Hubert Dichtl Matthew Weston Yashraj Rajani Adam Berlin Li Peng Rand Paul Lindsey Graham Georges Elhedery Narendra Modi Joe Rogan Howard Lutnick

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings